Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 45.49
-0.05 (-0.11%)
At close: Apr 29, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 7.60 billion as of April 29, 2026. Its market cap has increased by 16.38% in one year.
Market Cap
7.60B
Enterprise Value
6.37B
Revenue
838.12M
Ranking
n/a
PE Ratio
44.85
Stock Price
45.49
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 7.60B, a decrease of -43.69%. That is a compound annual growth rate of -11.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 7.60B | -15.87% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 7.64B |
| Jiangsu Aidea Pharmaceutical Group | 7.44B |
| Chengdu Kanghua Biological Products | 7.43B |
| Daan Gene | 8.11B |
| GemPharmatech | 8.17B |
| Suzhou Fengbei Biotech Stock | 7.19B |
| Zhejiang Ausun Pharmaceutical | 8.47B |
| Anhui Huaheng Biotechnology | 6.94B |